A drug shortage is considered resolved when all suppliers either have all products back in stock, or have discontinued those products. For this reason, products remain on the shortage list, despite intermittent or partially restored availability. Examples include:
- products on allocation
- products with distribution restrictions(for example, through a special program like Doxil® C.A.R.E.S.)
- products not available in the desired form, e.g., epinephrine in vials, but not syringes; heparin in vials, but not pre-mixed infusions;
- products in shortage for which imported alternatives are temporarily available.